Ceftazidime-Avibactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination for the Treatment of Resistant Gram-negative Organisms

Authors

Roopali Sharma, Touro College of Pharmacy (New York)Follow
Tae Eun Park, Touro College of Pharmacy (New York)Follow
Stanley Moy

Document Type

Article

Publication Date

2016

Recommended Citation

Sharma, R., Park, T. E., & Moy, S. (2016). Ceftazidime-avibactam: A novel cephalosporin/β-lactamase inhibitor combination for the treatment of resistant gram-negative organisms. Clinical Therapeutics, 38(3), 431-444. doi:10.1016/j.clinthera.2016.01.018

Publisher's Statement

The original material can be found here: https://doi:10.1016/j.clinthera.2016.01.018